136 related articles for article (PubMed ID: 28685785)
41. The Fen1 extrahelical 3'-flap pocket is conserved from archaea to human and regulates DNA substrate specificity.
Friedrich-Heineken E; Hübscher U
Nucleic Acids Res; 2004; 32(8):2520-8. PubMed ID: 15131255
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of FEN1 promotes DNA damage and enhances chemotherapeutic response in prostate cancer cells.
Wang Z; Yong C; Fu Y; Sun Y; Guo Z; Liu SB; Hu Z
Med Oncol; 2023 Jul; 40(8):242. PubMed ID: 37452976
[TBL] [Abstract][Full Text] [Related]
43. Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy.
Yang F; Hu Z; Guo Z
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883563
[TBL] [Abstract][Full Text] [Related]
44. A DNA Nano Firework for Imaging and Inhibitor Screening of Flap Endonuclease 1 in Living Cells.
Wang C; Hao D; Bao Y; Xu X; Li Y; Zou B; Ding L; Song Q
Anal Chem; 2023 Jun; 95(22):8621-8631. PubMed ID: 37218062
[No Abstract] [Full Text] [Related]
45. Cytotoxicity and DNA topoisomerase inhibitory activity of benz[f]indole-4,9-dione analogs.
Park HJ; Lee HJ; Lee EJ; Hwang HJ; Shin SH; Suh ME; Kim C; Kim HJ; Seo EK; Lee SK
Biosci Biotechnol Biochem; 2003 Sep; 67(9):1944-9. PubMed ID: 14519980
[TBL] [Abstract][Full Text] [Related]
46. An evolutionarily conserved synthetic lethal interaction network identifies FEN1 as a broad-spectrum target for anticancer therapeutic development.
van Pel DM; Barrett IJ; Shimizu Y; Sajesh BV; Guppy BJ; Pfeifer T; McManus KJ; Hieter P
PLoS Genet; 2013; 9(1):e1003254. PubMed ID: 23382697
[TBL] [Abstract][Full Text] [Related]
47. Target-activated T7 transcription circuit-mediated multiple cycling signal amplification for monitoring of flap endonuclease 1 activity in cancer cells.
Zhang JZ; Zhao NN; Wang ZY; Hu J; Zhang CY
Analyst; 2023 Jun; 148(12):2732-2738. PubMed ID: 37232199
[TBL] [Abstract][Full Text] [Related]
48. Improving virtual screening predictive accuracy of Human kallikrein 5 inhibitors using machine learning models.
Fang X; Bagui S; Bagui S
Comput Biol Chem; 2017 Aug; 69():110-119. PubMed ID: 28601761
[TBL] [Abstract][Full Text] [Related]
49. Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery.
Fang J; Yang R; Gao L; Zhou D; Yang S; Liu AL; Du GH
J Chem Inf Model; 2013 Nov; 53(11):3009-20. PubMed ID: 24144102
[TBL] [Abstract][Full Text] [Related]
50. Versatile Types of DNA-Based Nanobiosensors for Specific Detection of Cancer Biomarker FEN1 in Living Cells and Cell-Free Systems.
Zhang H; Ba S; Mahajan D; Lee JY; Ye R; Shao F; Lu L; Li T
Nano Lett; 2018 Nov; 18(11):7383-7388. PubMed ID: 30336066
[TBL] [Abstract][Full Text] [Related]
51. [Expression and activity assay of recombinant flap endonuclease 1].
Sheng N; Ma Y; Wang J; Zou B; Zhou G
Sheng Wu Gong Cheng Xue Bao; 2016 Oct; 32(10):1433-1442. PubMed ID: 29027452
[TBL] [Abstract][Full Text] [Related]
52. Mapping the FEN1 interaction domain with hTERT.
Sampathi S; Chai W
Biochem Biophys Res Commun; 2011 Apr; 407(1):34-8. PubMed ID: 21345332
[TBL] [Abstract][Full Text] [Related]
53. Functional FEN1 polymorphisms are associated with DNA damage levels and lung cancer risk.
Yang M; Guo H; Wu C; He Y; Yu D; Zhou L; Wang F; Xu J; Tan W; Wang G; Shen B; Yuan J; Wu T; Lin D
Hum Mutat; 2009 Sep; 30(9):1320-8. PubMed ID: 19618370
[TBL] [Abstract][Full Text] [Related]
54. Structure-based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1.
Guerreiro PS; Estácio SG; Antunes F; Fernandes AS; Pinheiro PF; Costa JG; Castro M; Miranda JP; Guedes RC; Oliveira NG
Chem Biol Drug Des; 2016 Dec; 88(6):915-925. PubMed ID: 27450574
[TBL] [Abstract][Full Text] [Related]
55. Role of FEN1 S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development.
Zhou L; Dai H; Wu J; Zhou M; Yuan H; Du J; Yang L; Wu X; Xu H; Hua Y; Xu J; Zheng L; Shen B
FASEB J; 2017 Jan; 31(1):132-147. PubMed ID: 27694478
[TBL] [Abstract][Full Text] [Related]
56. A cryptic targeting signal creates a mitochondrial FEN1 isoform with tailed R-Loop binding properties.
Kazak L; Reyes A; He J; Wood SR; Brea-Calvo G; Holen TT; Holt IJ
PLoS One; 2013; 8(5):e62340. PubMed ID: 23675412
[TBL] [Abstract][Full Text] [Related]
57. The human Rad9-Rad1-Hus1 checkpoint complex stimulates flap endonuclease 1.
Wang W; Brandt P; Rossi ML; Lindsey-Boltz L; Podust V; Fanning E; Sancar A; Bambara RA
Proc Natl Acad Sci U S A; 2004 Nov; 101(48):16762-7. PubMed ID: 15556996
[TBL] [Abstract][Full Text] [Related]
58. QSAR and Docking Studies of N-hydroxy Urea Derivatives as Flap Endonuclease-1 Inhibitors.
Wadhwa P; Jain P; Jadhav HR
Curr Comput Aided Drug Des; 2015; 11(4):346-52. PubMed ID: 26603927
[TBL] [Abstract][Full Text] [Related]
59. FEN1 inhibitor SC13 promotes CAR-T cells infiltration into solid tumours through cGAS-STING signalling pathway.
Dong Y; Wang Y; Yin X; Zhu H; Liu L; Zhang M; Chen J; Wang A; Huang T; Hu J; Liang J; Guo Z; He L
Immunology; 2023 Nov; 170(3):388-400. PubMed ID: 37501391
[TBL] [Abstract][Full Text] [Related]
60. Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer.
Liu L; Zhou C; Zhou L; Peng L; Li D; Zhang X; Zhou M; Kuang P; Yuan Q; Song X; Yang M
Carcinogenesis; 2012 Jan; 33(1):119-23. PubMed ID: 22072618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
